UA-145931898-1

Nuclear Medicine or Radiopharmaceuticals Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2

Comments · 160 Views

Nuclear Medicine or Radiopharmaceuticals Market was valued at USD 5700 million in 2021 and is expected to reach USD 9520 million by the year 2028, at a CAGR of 7.6%.

Nuclear medicine is the usage of radioactive substances in diagnostic or therapeutic procedures, particularly to treat various forms of cancer. Nuclear medicine employed in diagnosing or imaging process utilizes small amounts of radioactive substances called radiotracers. These radiotracers are generally injected into the bloodstream, inhaled, or swallowed by the patient where they localize to specific organs and emit radiation. The radiotracer moves through the area that is to be examined and radiates energy in the form of gamma rays. These gamma rays are detected by a special camera and a computer that generates images of the inner side of the body. Nuclear medicine imaging provides detailed unique information that is difficult to obtain using other imaging methods and it also has the potential to identify disease in its earliest stages. Moreover, radiopharmaceuticals are also administered as medicinal solutions containing radioisotopes. These radioactive medicines can destroy cancerous cells by emitting radiation when they reach the target cell.

This Nuclear Medicine or Radiopharmaceuticals Market Report includes information on the manufacturer, such as shipping, pricing, revenue, interview records, gross profit, and company distribution, among other things. These details assist consumers to learn more about their rivals. Likewise, the report outlines the significant difficulties that would have an influence market growth. They also give extensive facts about the industry's potential to key stakeholders, allowing them to expand their industries and increase sales in certain industries. The research will assist companies who are already in or want to enter this market in analyzing the many facets of this domain before investing in or growing their industry in the Nuclear Medicine or Radiopharmaceuticals markets.

To learn more about this report, request a free sample copy:

https://introspectivemarketresearch.com/request/15924

Key Industry Players in Nuclear Medicine or Radiopharmaceuticals Market:

  • Actinium Pharmaceuticals Inc. (US)
  • Alliance Medical (UK)
  • Avid Bioservices Inc (US)
  • Bayer HealthCare Pharmaceuticals (Germany)
  • Bracco Diagnostics Inc. (Italy)
  • Cardinal Health Inc. (US)
  • GE Healthcare (US)
  • Ion Beam Applications S.A (Belgium)
  • Jubilant Pharma (India)
  • Lantheus Medical Imaging Inc. (US)
  • Medi-Radiopharma Ltd (Hungary)
  • Nordion Inc. (Canada)
  • Novartis/Advanced Accelerator Applications (France)
  • Positron Corporation (US)
  • Radiopharm Theranostics Ltd. (US), and other major players.

Nuclear medicine is majorly used for diagnosing CVD and cancers. The saturation of these markets has prompted a number of companies and stakeholders to focus on expanding the overall applications of radiopharmaceuticals. With the expanding application areas of radiopharmaceuticals, their demand and uptake are expected to increase in the coming years. This indicates an opportunity for players to expand their offerings and market shares by catering to the demand for radiopharmaceuticals in neurological applications.

Segmentation Analysis Includes,

By Type:

  • Diagnostic
  • Therapeutic
  • Research

By Modality:

  • Single-Photon Emission Computed Tomography (SPECT) Radioisotopes
  • Positron Emission Tomography (PET) Radioisotopes
  • Beta Emitters
  • Alpha Emitters
  • Others

By Application:

  • Oncology
  • Thyroid
  • Cardiology
  • Neurology
  • Others

By End User:

  • Hospitals and Diagnostic Centers
  • Research Institutes

By Region:

  • North America (U.S., Canada, Mexico)
  • Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
  • Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
  • Middle East Africa (Turkey, Saudi Arabia, Iran, UAE, Africa, Rest of MEA)
  • South America (Brazil, Argentina, Rest of SA)

 Will you have any doubt about this report? Please contact us on:   

https://introspectivemarketresearch.com/inquiry/15924

Table of Content:

Chapter 1: Introduction

 1.1 Research Objectives

 1.2 Research Methodology

 1.3 Research Process

 1.4 Scope and Coverage

  1.4.1 Market Definition

  1.4.2 Key Questions Answered

 1.5 Market Segmentation

Chapter 2: Executive Summary

Chapter 3: Growth Opportunities By Segment

 3.1 By Type

 3.2 By Modality

 3.3 By Application

 3.4 By End User

Chapter 4: Market Landscape

 4.1 Porter's Five Forces Analysis

  4.1.1 Bargaining Power of Supplier

  4.1.2 Threat of New Entrants

  4.1.3 Threat of Substitutes

  4.1.4 Competitive Rivalry

  4.1.5 Bargaining Power Among Buyers

 4.2 Industry Value Chain Analysis

 4.3 Market Dynamics

Continue…

Nuclear medicines are a group of pharmaceutical drugs that contain radioactive isotopes. They are exclusive medicinal formulations with radioisotopes and are used in major clinical areas for diagnosis or therapy.  Over the past few years, radiopharmaceutical therapies have emerged as one of the most efficient techniques in various areas, such as neurology, cardiology, oncology, and others.

Purchase This Report: -

https://introspectivemarketresearch.com/checkout/?user=1_sid=15924

The objective of the report is to present comprehensive Global Nuclear Medicine/Radiopharmaceuticals Market including all the stakeholders of the industry. The past and current status of the industry with forecasted market size and trends are presented in the report with analysis of complicated data in simple language. The report covers all the aspects of industry with dedicated study of key players that includes market leaders, followers and new entrants by region. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors by region on the market have been presented in the report.

Related Report: -

https://introspectivemarketresearch.com/reports/nuclear-imaging-devices-market/

https://introspectivemarketresearch.com/reports/chemical-biological-radiological-and-nuclear-cbrn-security-market/

About us:

Introspective Market Research (introspectivemarketresearch.com) is a visionary research consulting firm dedicated to assisting our clients to grow and have a successful impact on the market. Our team at IMR is ready to assist our clients to flourish their business by offering strategies to gain success and monopoly in their respective fields. We are a global market research company, that specializes in using big data and advanced analytics to show the bigger picture of the market trends. We help our clients to think differently and build better tomorrow for all of us. We are a technology-driven research company, we analyze extremely large sets of data to discover deeper insights and provide conclusive consulting. We not only provide intelligence solutions, but we help our clients in how they can achieve their goals.

Contact us:

Introspective Market Research

3001 S King Drive,

Chicago, Illinois

60616 USA

Ph no: +1-773-382-1047

Linkedin| Twitter| Facebook

Email: sales@introspectivemarketresearch.com

Comments